Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Nasdaq

Intel Shares Surge on Renewed Apple Partnership Speculation

Dieter Jaworski by Dieter Jaworski
November 30, 2025
in Nasdaq, Semiconductors, Tech & Software, Turnaround
0
Intel Stock
0
SHARES
23
VIEWS
Share on FacebookShare on Twitter

Intel’s stock experienced a dramatic surge following fresh industry speculation about a potential revival of its manufacturing relationship with Apple. This development has injected significant optimism into the outlook for the U.S. chipmaker, which many had previously written off in the competition for advanced manufacturing technologies, particularly after Apple transitioned to its own custom silicon designs.

Analyst Report Sparks Rally

The catalyst for the substantial price movement was an analysis from respected industry expert Ming-Chi Kuo. According to his assessment, the probability of Intel securing future manufacturing contracts with Apple has seen “significant improvement.” This evaluation carries substantial weight within the technology sector and immediately captured investor attention.

Behind the scenes, several developments suggest concrete progress. Reports indicate that Apple has not only entered into a non-disclosure agreement with Intel but is already gaining access to Intel’s advanced 18A process technology. Specifically, this potential collaboration could involve Intel manufacturing Apple’s M-series processors for iPad and MacBook Air devices beginning in 2027. Such an agreement would represent far more than a conventional customer contract—it would serve as a powerful endorsement of Intel’s revised technological roadmap.

Strategic Timing for Foundry Business

This potential partnership emerges at a crucial juncture for Intel. Under CEO Lip-Bu Tan’s leadership, the company has been aggressively pursuing profitability for its foundry division, which handles semiconductor manufacturing for third-party clients. This business segment has previously struggled with substantial financial losses and a notable absence of major external customers.

Should investors sell immediately? Or is it worth buying Intel?

A manufacturing deal with Apple would deliver both immediate financial benefits and strategic advantages. It would align perfectly with governmental “Made in USA” initiatives, through which Intel has already received billions in subsidies aimed at reducing dependence on Asian market leader TSMC. Technologically, Intel is leveraging innovations like its PowerVia backside power delivery technology, designed to substantially improve chip efficiency—precisely the performance characteristics Apple requires for its mobile devices.

Market Reaction and Analyst Caution

Investors responded enthusiastically to the positive signals, driving Intel shares up by a remarkable 11.48% to €35.16 in Friday’s trading session. This surge extends the stock’s impressive recovery trajectory, with shares having gained over 78% since the beginning of the year.

Despite this market euphoria, many analysts maintain a cautious stance. Experts emphasize that no formal contract has been finalized, and mass production remains several years away. Consequently, the majority of market watchers continue to rate Intel stock as either “Hold” or “Sell,” advising investors to temper immediate expectations.

The central question remains whether this development marks the beginning of sustained growth or represents a temporary rally. The answer will ultimately depend on Intel’s ability to deliver on its ambitious technological promises by the 2026 timeframe.

Ad

Intel Stock: Buy or Sell?! New Intel Analysis from March 25 delivers the answer:

The latest Intel figures speak for themselves: Urgent action needed for Intel investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Intel: Buy or sell? Read more here...

Tags: Intel
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock
AI & Quantum Computing

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Next Post
QuantumScape Stock

QuantumScape Executive's Major Stock Sale Raises Investor Concerns

Uranium Energy Stock

Uranium Energy Stock Faces Critical Earnings Test

Kraft Heinz Stock

Kraft Heinz Shares: A Tale of Investor Division and Brand Challenges

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com